Laboratorios Farmaceúticos Rovi SA (LABFF)
65.86
0.00 (0.00%)
USD |
OTCM |
May 19, 16:00
Laboratorios Farmaceúticos Rovi EPS Diluted (Quarterly) : 0.2168 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Almirall SA | 0.0833 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.05M |
| Revenue (Quarterly) | 178.41M |
| Total Expenses (Quarterly) | 167.32M |
| Enterprise Value | 3.403B |
| Gross Profit Margin (Quarterly) | 55.56% |
| Profit Margin (Quarterly) | 6.20% |
| Earnings Yield | 4.54% |
| Operating Earnings Yield | 5.52% |
| Normalized Earnings Yield | 4.541 |